This inventor holds 1 USPTO granted patent. Top assignee: Helmholtz Zentrum Munchen Deutsches Forschungszentrum Fur Gesundheit Und Umwelt. Active years: 2013.
Company Filing History:
Years Active: 2013
Title: Ralf Kuehn: Innovator in Fusion Protein Technology
Introduction
Ralf Kuehn is a notable inventor based in Freising, Germany. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. His work focuses on innovative solutions for medical applications, including cancer treatment.
Latest Patents
Ralf Kuehn holds a patent for a fusion protein comprising a Caspase domain and a nuclear hormone receptor binding domain. This invention relates to a fusion protein that includes a Caspase domain or a functionally active variant and a ligand binding domain of a nuclear hormone receptor. The patent outlines various methods and uses of this fusion protein, including its application in inducing apoptosis in cells and studying cellular functions. The invention also encompasses a nucleic acid coding for the fusion protein, a vector or cell containing the nucleic acid, and the use of a transgenic organism for research purposes.
Career Highlights
Kuehn is affiliated with the Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt. His work at this prestigious research institution has allowed him to explore groundbreaking advancements in health and environmental sciences. His innovative approach has led to the development of technologies that could potentially transform cancer treatment and transplantation safety mechanisms.
Collaborations
Ralf Kuehn has collaborated with esteemed colleagues such as Wolfgang Wurst and Yuanyuan Chu. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in their respective fields.
Conclusion
Ralf Kuehn's contributions to the field of fusion protein technology exemplify the impact of innovative research on medical science. His patent and ongoing work at Helmholtz Zentrum München highlight the importance of collaboration and creativity in advancing healthcare solutions.